The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design
GR Tundo, G Grasso, M Persico, O Tkachuk, F Bellia… - Biomolecules, 2023 - mdpi.com
The insulin-degrading enzyme (IDE) is a Zn2+ peptidase originally discovered as the main
enzyme involved in the degradation of insulin and other amyloidogenic peptides, such as …
enzyme involved in the degradation of insulin and other amyloidogenic peptides, such as …
Insulin-Degrading Enzyme, an Under-Estimated Potential Target to Treat Cancer?
L Lesire, F Leroux, R Deprez-Poulain, B Deprez - Cells, 2022 - mdpi.com
Insulin-degrading enzyme (IDE) is a multifunctional protease due to the variety of its
substrates, its various cellular locations, its conservation between species and its many non …
substrates, its various cellular locations, its conservation between species and its many non …
[HTML][HTML] Effects of red rice bran extract on high-fat diet-induced obesity and insulin resistance in mice
N Munkong, A Thim-Uam, S Pengnet… - … Nutrition and Food …, 2022 - ncbi.nlm.nih.gov
Insulin resistance is a salient player in the pathogenesis of obesity and its related abnormal
glucose-insulin homeostasis. Red rice bran extract (RRBE) demonstrates several bioactive …
glucose-insulin homeostasis. Red rice bran extract (RRBE) demonstrates several bioactive …
Pharmacological activation of insulin‐degrading enzyme improves insulin secretion and glucose tolerance in diet‐induced obese mice
A Sanz‐González, I Cózar‐Castellano… - Diabetes, Obesity …, 2023 - Wiley Online Library
Aim To investigate the use of synthetic preimplantation factor (sPIF) as a potential
therapeutic tool for improving glucose‐stimulated insulin secretion (GSIS), glucose tolerance …
therapeutic tool for improving glucose‐stimulated insulin secretion (GSIS), glucose tolerance …
Sirt3 deficiency induced down regulation of insulin degrading enzyme in comorbid Alzheimer's disease with metabolic syndrome
A Tyagi, M Musa, W Labeikovsky, S Pugazhenthi - Scientific reports, 2022 - nature.com
SIRT3 deacetylates mitochondrial proteins, thereby enhancing their function. We have
previously demonstrated that Sirt3 gene deletion leads to brain mitochondrial dysfunction …
previously demonstrated that Sirt3 gene deletion leads to brain mitochondrial dysfunction …
Ginsenoside Rg1 promotes β‑amyloid peptide degradation through inhibition of the ERK/PPARγ phosphorylation pathway in an Alzheimer's disease neuronal model
Q Quan, X Ma, M Li, X Li… - Experimental and …, 2023 - spandidos-publications.com
β-Amyloid peptide (Aβ) deposition in the brain is an important pathological change in
Alzheimer's disease (AD). Insulin-degrading enzyme (IDE), which is regulated …
Alzheimer's disease (AD). Insulin-degrading enzyme (IDE), which is regulated …
Maternal high fat diet anticipates the AD-like phenotype in 3xTg-AD mice by epigenetic dysregulation of Aβ metabolism
Maternal overnutrition has been reported to affect brain plasticity of the offspring by altering
gene expression, regulating both synaptic plasticity and adult neurogenesis. However …
gene expression, regulating both synaptic plasticity and adult neurogenesis. However …
Hepatic metabolite responses to 4-day complete fasting and subsequent refeeding in rats
X Sui, H Wang, F Wu, C Yang, H Zhang, Z Xu, Y Guo… - PeerJ, 2022 - peerj.com
Background Fasting has been widely used to improve various metabolic diseases in
humans. Adaptive fasting is necessary for metabolic adaptation during prolonged fasting …
humans. Adaptive fasting is necessary for metabolic adaptation during prolonged fasting …
Long‐Term High‐Fat Diet Decreases Renal Insulin‐Degrading Enzyme Expression and Function by Inhibiting the PPARγ Pathway
Q Su, J Huang, X Chen, Y Wang… - Molecular nutrition & …, 2023 - Wiley Online Library
Scope Long‐term high‐fat diet (HFD) causes insulin resistance, which is a primary
etiological factor in the development of obesity and type 2 diabetes mellitus. Impaired insulin …
etiological factor in the development of obesity and type 2 diabetes mellitus. Impaired insulin …
[PDF][PDF] Antidiabetic effects of marine brown algae Spatoglossum asperum J. Ag. ethanolic extract on 3T3-L1 Pre-Adipocytes activity an in vitro approach
A Sekar, A Pandian, R Veerabathiran… - International journal of …, 2022 - academia.edu
Marine algae have emerged as good alternative source of medical, pharmaceutical, and
food industries, it's used for anticancer, anti-inflammatory, antioxidant, antimicrobial, etc., In …
food industries, it's used for anticancer, anti-inflammatory, antioxidant, antimicrobial, etc., In …